X-Feed Billboard (International)

The newsboard processes news from the NASDAQ Nordic portfolio company GlobeNewswire, which provides investors with company-relevant information. This relates in particular to events that may be relevant to the listing of companies or tradable financial instruments.

GlobNewswire (formerly PrimeNewswire) specializes in public relations solutions and digital media services. This feed adds another important source of information for investors to the popular X-Billboard portfolio.

F&G: 68
5.775,07 S&P · 22,20 Vola-Index · 109.921,11 BTC · 1,13210 EURUSD
System-State: Number of processed items 71.257 Notifications successully processed since Inception
EXCHANGE NEWSBOARD
                              
NEWSWIRE INFOBOARD
                              
GlobeNewsWire ist eine wichtige Nachrichtenquelle, die über das X-Billboard abgerufen werden kann. Sie ist Teil des Newswire-Hub, der für Börsianer wichtige internationalen Nachrichtenquellen an einem zentralen Ort bündelt. Wer sich schnell einen Überblick verschaffen will, kann sich bequem durch die Headlines scrollen. Wer sich detailliert mit den Nachrichten auseinandersetzen möchte, kann über die Detailansichten der Info-Cards direkt auf die jeweilige Nachricht und weitere Analysewerkzeuge zugreifen.
NEWS
EXPLORER
US29350E1047
State: 23.05.2025 | 3PM
Do you already know our new terminal view? Click here.
FIGI: BBG0060CNMG8
RENB

Renovaro Biosciences Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
NAME
Renovaro Biosciences Inc.
ISIN
US29350E1047
TICKER
RENB
MIC
XNAS
REUTERS
RENB.OQ
BLOOMBERG
RENB US
Thu, 22.05.2025       Renovaro Biosciences

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
Thu, 22.05.2025       Renovaro Biosciences

Renovaro Inc. Announces Expedited Trail for 2025 Lawsuit to Enforce Binding Merger Agreement with Predictive Oncology
Wed, 14.05.2025       Renovaro Biosciences

Renovaro Launches Augusta, an AI-Powered Precision Neurology Platform
Tue, 13.05.2025       Renovaro Biosciences

Renovaro and Amsterdam University Medical Center Announce Exclusive Collaboration to Advance Blood Platelet RNA Diagnostics
Tue, 22.04.2025       Renovaro Biosciences

Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs
Wed, 09.04.2025       Renovaro Biosciences

Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine
Fri, 04.04.2025       Renovaro Biosciences

Renovaro Provides Update to Definitive Agreement with Predictive Oncology
Mon, 03.03.2025       Renovaro Biosciences

Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
Wed, 26.02.2025       Renovaro Biosciences

Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine
Wed, 26.02.2025       Renovaro Biosciences

Renovaro Announces $15 million in Equity Committed
Tue, 07.01.2025       Renovaro Biosciences

Renovaro Issues Shareholder Letter and Provides Corporate Update
Tue, 07.01.2025       Renovaro Biosciences

Renovaro Appoints Nathen Fuentes as Chief Financial Officer
Mon, 06.01.2025       Renovaro Biosciences

Renovaro to Acquire Predictive Oncology in All-Stock Transaction
Mon, 30.12.2024       Renovaro Biosciences

Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV
Fri, 20.12.2024       Renovaro Biosciences

Renovaro Regains Compliance with NASDAQ Listing Requirement
Thu, 17.10.2024       Renovaro Biosciences

AMSTERDAM, Oct. 17, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) – RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the presentation of its latest research at the Molecular Analysis for Precision Oncology Congress – on October 16, 2024.

Wed, 16.10.2024       Renovaro Biosciences

LOS ANGELES, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, today announced a strategic restructuring and leadership transition of senior management and the Board of Directors to realign resources focused on the Company’s AI Platform, RenovaroCube for multi-cancer early detection and patient monitoring. The Board, with the support of a supermajority of shareholders, appointed David Weinstein as director and new CEO and four new directors – Maurice van Tilburg, Chairman, Douglas Calder, James A. McNulty CPA, and Mark A. Collins PhD.

Fri, 13.09.2024       Renovaro Biosciences

AMSTERDAM, Sept. 13, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) RenovaroCube (Cube, the Company), a leading AI-driven innovator using multi-omics technology for cancer profiling, is pleased to announce two scientific presentations at a leading cancer conference – the European Society for Medical Oncology (ESMO) Congress – on September 15, 2024.

Wed, 11.09.2024       Renovaro Biosciences

AMSTERDAM, Sept. 11, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RENB) The Board of Renovaro, Inc (RENB) intends to seek strategic investors to acquire up to 20% of RenovaroCube (Cube), currently a wholly owned subsidiary.

Fri, 14.06.2024       Renovaro Biosciences

Renovaro Announces $10m in Equity Committed

The information provided here is not subject to any editorial processing. It is prepared fully automatically and enriched with additional information and further research options. The aim of the content is to provide information seekers with the relevant information quickly and easily. A link back to the information provider and owner ensures that the data prepared here can be compared with the source information if required. The newsboard does not show information in real time. Please contact the exchange operator for this information if required. There is no claim to completeness. High availability cannot be guaranteed. If you notice any errors in the functionality, please let us know using the "Report a Bug" form below.

RAW DATA PROCESSING means that raw data is processed without changing the content. The data is supplemented to improve the interpretation of the information in terms of usability.

Note: The newswire cross-link panel at the top allows you to quickly and easily access additional sources of information. In the terminal view, the news is filtered at company level and enables targeted searches.


On behalf of the trading community, we would like to thank the operators of the trading venues for providing information services.